Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [American Association for Thoracic Surgery]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CR7应助暴走小面包采纳,获得20
1秒前
1秒前
领导范儿应助victor采纳,获得10
1秒前
tumankol发布了新的文献求助10
1秒前
2秒前
一条鱼完成签到,获得积分10
2秒前
clear发布了新的文献求助10
3秒前
磊磊磊发布了新的文献求助10
3秒前
小马甲应助blUe采纳,获得10
3秒前
量子星尘发布了新的文献求助10
4秒前
吴硫完成签到,获得积分10
4秒前
5秒前
英俊的铭应助变化采纳,获得10
6秒前
6秒前
量子星尘发布了新的文献求助10
8秒前
0227Y发布了新的文献求助10
8秒前
北溟鱼完成签到,获得积分10
9秒前
9秒前
9秒前
9秒前
10秒前
Luna完成签到 ,获得积分10
10秒前
clear完成签到,获得积分20
10秒前
野性的烧鹅完成签到,获得积分10
10秒前
熬夜波比应助hsa_ID采纳,获得10
11秒前
Akim应助科研通管家采纳,获得10
12秒前
无花果应助科研通管家采纳,获得10
12秒前
北溟鱼发布了新的文献求助10
12秒前
李爱国应助科研通管家采纳,获得10
13秒前
大个应助科研通管家采纳,获得10
13秒前
所所应助科研通管家采纳,获得10
13秒前
在水一方应助科研通管家采纳,获得10
13秒前
情怀应助科研通管家采纳,获得10
13秒前
爆米花应助科研通管家采纳,获得10
13秒前
jyy应助科研通管家采纳,获得10
13秒前
NexusExplorer应助科研通管家采纳,获得10
13秒前
无极微光应助科研通管家采纳,获得20
13秒前
July应助科研通管家采纳,获得10
13秒前
July应助科研通管家采纳,获得10
14秒前
bkagyin应助科研通管家采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Binary Alloy Phase Diagrams, 2nd Edition 8000
Comprehensive Methanol Science Production, Applications, and Emerging Technologies 2000
Building Quantum Computers 800
Translanguaging in Action in English-Medium Classrooms: A Resource Book for Teachers 700
二氧化碳加氢催化剂——结构设计与反应机制研究 660
碳中和关键技术丛书--二氧化碳加氢 600
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5660407
求助须知:如何正确求助?哪些是违规求助? 4833752
关于积分的说明 15090568
捐赠科研通 4819045
什么是DOI,文献DOI怎么找? 2578992
邀请新用户注册赠送积分活动 1533551
关于科研通互助平台的介绍 1492304